Zoledronate Funding Subsidy Changes
June 5, 2019
Maximum funding cap reached for 2018-19 funding year
Counties Manukau Health provides funding to subsidise zoledronate (aclasta) infusions for eligible patients.
Funding of a maximum of 300 patients is available per year. For the period ending June 2019 this maximum funding allocation has now been reached.Funding will re...
Acute Pelvic Pain in Young Women
May 28, 2019
This pathway assists GPs with navigating through the causes of pelvic pain in young women to decide a provisional diagnosis and thereby refer to the correct service, or appropriately investigate and follow-up in the community. Please note there are limited indications f...
Management of cellulitis accompanying an abscess
April 12, 2019
In January 2019 new pathways were published for Skin and Soft Tissue Abscess in Adults, Mastitis and Breast Abscess and Bartholin’s Cyst or Abscess. Communications were sent via Medinz and the POAC blog – click here to sign up
Following review by the regional Antimi...
Changes to Hepatitis C Treatment
February 1, 2019
Hepatitis C Treatment - Update to pathway and claiming process
The Chronic Hepatitis C pathway has been updated for the newly funded direct acting antiviral (DAA) medication, Maviret™.
Maviret™ is the recommended treatment in primary care for a majority of patients with Hepatitis C who do not have cirrhosis:
Cure rate of 99%...
New Abscess Management Pathways
January 31, 2019
Primary Care communications for new abscess management pathways
Auckland Regional HealthPathways has developed three new pathways for abscess management:
Skin and soft tissue abscess in adultsBartholin's cyst or abscess Mastitis and breast abscess
These best practice regionally agreed pathways have been developed with both primary a...
Hospital Referral to Urgent Care/GP Clinic
January 15, 2019
The process for hospital referrals under POAC:
When a patient attends Urgent Care with a hospital discharge summary stating for further POAC funded treatment, this includes the following principles:
The Urgent Care clinic generates the POAC referral/case number when the patient attendsThe initial consult and all treatmen...
Christmas and New Year Holiday Period
December 20, 2018
POAC OVER THE HOLIDAY PERIOD
Thank you for your support over the year, we look forward to an exciting 2019.
From our team to yours, Merry Christmas and a safe and happy holiday season!
POAC HOURS OVER THE HOLIDAY:
The POAC coordinators are taking a well deserved break over the Christmas and ...
Pelvic Ultrasound Funding
November 7, 2018
POAC funds pelvic ultrasound scans for the following conditions:
Suspected retained products of conception beyond Section 88 funded scan time period.
Persistent, heavy PV bleeding lasting more than 2 weeks following miscarriage or termination of pregnancy, or more than 6 weeks post-delivery, to rule out retained products of conception. Fo...
Rivaroxaban funding
September 17, 2018
Rivaroxaban not indicated or funded before POAC DVT scan
In line with the Auckland Regional HealthPathway, when there is a delay in obtaining community ultrasound for DVT, Enoxaparin continues to be the medication to be administered and funded through POAC.
The issue of using rivaroxaban instead of enoxaparin for anticoagulation c...
DVT Risk Stratification
June 27, 2018
A reminder that the first action for suspected DVT is completion of Wells Score.
ONLY if <2 is a d-dimer required. If score is 2 or more then proceed directly to request for ultrasound.
Awaiting d-dimer delays the ultrasound request and this may not be necessary
For...
Loading...
TAGS
abscesscellulitisdvtECGAcute ECGantibioticBARTHOLIN'S ABSCESSboilBREAST ABSCESScephazolincystectopicFAQsFerinjectgynaeHep CHepatitisIVIV ironmaternityMaviretNurse AdvisorOSTovarianovarian cystovarian torsionpaediatric cellulitispelvic painpelvic scanpelvic ussPIDPOAC ECGpoac pelvic\RivaroxabanSarah Hydersore throattonsilitisTroponinwells score
Loading...